India to Turkey: Ustekinumab Export Trade Route
India has recorded 5 verified shipments of Ustekinumab exported to Turkey, representing a combined trade value of $36.9K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $7.4K USD. The leading Indian exporter is MEDICINE HOUSE, which accounts for 100% of total export value with 5 shipments worth $36.9K USD. On the buying side, IMPORT MANAGER INTERNATIONAL SALES CO is the largest importer in Turkey with $22.1K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkey Ustekinumab corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $36.9K USD. The route is dominated by MEDICINE HOUSE, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $7.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ustekinumab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 13.2%, placing it at rank #15 among India's top ustekinumab export destinations globally.
On the import side, key buyers of Indian ustekinumab in Turkey include IMPORT MANAGER INTERNATIONAL SALES CO, TO. IMPORT MANAGER INTERNATIONAL SALES CO is the single largest importer with 3 shipments valued at $22.1K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#15
- Annual growth+13.2%
- Demand growth+13.5%
- Regulatory ease74/100
Top 10 Indian Ustekinumab Exporters to Turkey
Showing top 10 of 1 Indian suppliers exporting Ustekinumab to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDICINE HOUSE Avg $7.4K per shipment | 5 | $36.9K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting ustekinumab to Turkey, ranked by total trade value. The listed exporters are: MEDICINE HOUSE. MEDICINE HOUSE is the dominant supplier with 5 shipments worth $36.9K USD, giving it a 100% market share.
Top 10 Ustekinumab Importers in Turkey
Showing top 10 of 2 known buyers in Turkey receiving Ustekinumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ustekinumab in Turkey include IMPORT MANAGER INTERNATIONAL SALES CO, TO. The largest importer is IMPORT MANAGER INTERNATIONAL SALES CO, accounting for $22.1K USD across 3 shipments — representing 60% of all ustekinumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IMPORT MANAGER INTERNATIONAL SALES CO | 3 | $22.1K | 59.8% |
| 2 | TO | 2 | $14.8K | 40.2% |
Top 10 Ustekinumab Formulations Imported by Turkey
Showing top 10 of 2 product formulations shipped on the India to Turkey Ustekinumab route, ranked by trade value
Turkey imports a wide range of ustekinumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICALS FOR HUMAN USE ONLY NON HAZARDOUS-INJ.STELARA USTEKINUMAB 90MG/1ML PFS MFR-JOHNSON & JOHNSON PRIVATE LIMITED BC — accounts for $22.1K USD across 3 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICALS FOR HUMAN USE ONLY NON HAZARDOUS-INJ.STELARA USTEKINUMAB 90MG/1ML PFS MFR-JOHNSON & JOHNSON PRIVATE LIMITED BC | 3 | $22.1K | 59.8% |
| 2 | PHARMACEUTICALS FOR HUMAN USE ONLY NON HAZARDOUS-INJ.STELARA (USTEKINUMAB) 90MG/1ML PFS MFR-JOHNSON & JOHNSON PVT LTD BC | 2 | $14.8K | 40.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 3 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's ustekinumab exports to Turkey are driven primarily by a handful of large-scale manufacturers. MEDICINE HOUSE with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MEDICINE HOUSE — together account for 100% of total trade value on this route. The average shipment value of $7.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceuticals for human use only non hazardous-inj.stelara (ustekinumab) 90mg/1ml pfs mfr-johnson & johnson pvt ltd bc, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, IMPORT MANAGER INTERNATIONAL SALES CO is the largest importer with 3 shipments worth $22.1K USD — representing 60% of all ustekinumab imports from India on this route.
Route Statistics
- Trade Volume
- $36.9K
- Avg. Shipment
- $7.4K
- Suppliers
- 1
- Buyers
- 2
- Transit (Sea)
- ~26 days
- Annual Growth
- +13.2%
Related Analysis
Other Ustekinumab Routes
Unlock the Full India to Turkey Ustekinumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 5 shipments on this route.
Frequently Asked Questions — India to Turkey Ustekinumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ustekinumab to Turkey?
The leading Indian exporters of Ustekinumab to Turkey are MEDICINE HOUSE. MEDICINE HOUSE holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Ustekinumab exports from India to Turkey?
India exports Ustekinumab to Turkey worth approximately $36.9K USD across 5 recorded shipments. The average value per shipment is $7.4K USD.
Q Which ports does India use to ship Ustekinumab to Turkey?
The most active port of origin is DELHI AIR with 3 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Turkey for Ustekinumab?
The average transit time for Ustekinumab shipments from India to Turkey is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Turkey Ustekinumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.2% with demand growth tracking at 13.5%. The route is ranked #15 among India's top Ustekinumab export destinations globally.
Q How many suppliers are active on the India to Turkey Ustekinumab route?
There are currently 1 active Indian suppliers exporting Ustekinumab to Turkey. The market is moderately concentrated with MEDICINE HOUSE accounting for 100% of total shipment value.
Q Who are the main importers of Ustekinumab from India in Turkey?
The leading importers of Indian Ustekinumab in Turkey include IMPORT MANAGER INTERNATIONAL SALES CO, TO. IMPORT MANAGER INTERNATIONAL SALES CO is the largest buyer with 3 shipments worth $22.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Ustekinumab.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 2 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 5 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists